ZEPP · Zepp Health Corp · Metrics
Market Cap
$70.39M
Shares
14.66M
ZEPP metrics
34 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$4.92
Market cap
$70.39M
Price action
20 metricsPrice change (1W)
-4.8%
Price change (30D)
-7.5%
Price change (3M)
-22.5%
Price change (6M)
-73.5%
Price change (YTD)
-82.2%
Price change (1Y)
-90.5%
Trailing year
Price change (5Y)
—
52-week high
$61.27
52-week low
$3.99
Change from 52-week high
-92.2%
Change from 52-week low
+20.3%
Annualized volatility
107.6%
Annualized volatility (3M)
102.3%
Beta
2.6
RSI (14D)
45.7
Price vs SMA 50
-4.8%
Price vs SMA 200
-67.7%
Avg volume (3M)
84,218
Relative volume
0.4
Average dollar volume
$412,042
Company
3 metricsSector
Technology
Industry
Consumer Electronics
Shares outstanding
14.66M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
2022-03-25
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-09-02
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
—
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
—
Debt / equity
—
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
—
Total assets
—
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
28
13F filer change QoQ
-7
Institutional ownership
15.9%
Short interest
3 metricsShort interest
2.6%
Latest settlement · 10.7 days to cover
Days to cover
10.7d
Short-squeeze score
66 / 100
Insider activity
2 metricsNet insider buying (90D)
−$45,344
Insider-sentiment score
45 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1720446
CUSIP
98945L204
13F (30d)
22 filings
22 filers
Visit website
Investor relations